Safety, Efficacy, and Pharmacokinetics of TBR-652, a CCR5/CCR2 Antagonist, in HIV-1–Infected, Treatment-Experienced, CCR5 Antagonist–Naive Subjects-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Safety, Efficacy, and Pharmacokinetics of TBR-652, a CCR5/CCR2 Antagonist, in HIV-1–Infected, Treatment-Experienced, CCR5 Antagonist–Naive Subjects

Published:2011-06-01 Issue:2 Volume:57 Page:118-125
ISSN:1525-4135
Container-title:JAIDS Journal of Acquired Immune Deficiency Syndromes
language:en
Short-container-title:

Author:

Lalezari Jacob,Gathe Joseph,Brinson Cynthia,Thompson Melanie,Cohen Calvin,Dejesus Edwin,Galindez Jorge,Ernst Jerome A,Martin David E,Palleja Sandra M

Publisher

Ovid Technologies (Wolters Kluwer Health)

Subject

Pharmacology (medical),Infectious Diseases

Reference22 articles.

1. Monocyte chemoattractant protein 1 (MCP-1): an overview.;Deshmane;J Interferon Cytokine Res,2009

2. Efficacy of short-term monotherapy with maraviroc, a new CCR5 antagonist, in patients infected with HIV-1.;Fatkenheuer;Nat Med,2005

3. TAK-652 inhibits CCR5-mediated human immunodeficiency virus type 1 infection in vitro and has favorable pharmacokinetics in humans.;Baba;Antimicrob Agents Chemother,2005

4. Immune activation and inflammation in HIV-1 infection: causes and consequences.;Appay;J Pathol,2008

5. for the INSIGHT SMART Study Group. Inflammatory and coagulation biomarkers and mortality in patients with HIV infection.;Kuller;PLoS Med,2008

Cited by 63 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Circulating and Synovial Monocytes in Arthritis and Ex-Vivo Model to Evaluate Therapeutic Modulation of Synovial Monocytes;Immunological Investigations;2023-08-24

2. Critical roles for CCR2 and the therapeutic potential of cenicriviroc in periodontitis: A pre‐clinical study;Journal of Clinical Periodontology;2022-08-04

3. The Continuous Surveillance of InSTI Resistance Could be an Important Public Health Tool in the Fight Against HIV Infection;Current HIV Research;2021-08-30

4. Therapeutic Approaches for Nonalcoholic Steatohepatitis ( NASH );Burger's Medicinal Chemistry and Drug Discovery;2021-04-28

5. Emerging therapies for the treatment of nonalcoholic steatohepatitis: A systematic review;Pharmacotherapy: The Journal of Human Pharmacology and Drug Therapy;2021-02-17

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3